BetaGlue Therapeutics
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
12
Total Funding
$49M
Investors
12 investors across all rounds
ET
Enea Tech e Biomedical
OTHER
EI
European Innovation Council (Belgium)
FP
Fin Posillipo
GC
Giovanni Cerutti
IC
Innogest Capital
Explore More Data
Detailed analysis for BetaGlue Therapeutics
BetaGlue Therapeutics Leadership & Investors
BetaGlue Therapeutics is led by a team of experienced leaders. The company has attracted investment from 12 institutional and strategic investors.
Who Has Invested in BetaGlue Therapeutics?
BetaGlue Therapeutics has raised $49M from 12 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access BetaGlue Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.